Asymptomatic Left Ventricular Hypertrophy Is a Potent Risk Factor for the Development of HFpEF but Not HFrEF: Results of a Retrospective Cohort Study

por Ovchinnikov, Artem, Belyavskiy, Evgeny, Potekhina, Alexandra, Ageev, Fail
Publicado 2022

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors

por Ovchinnikov, Artem, Potekhina, Alexandra, Belyavskiy, Evgeny, Ageev, Fail
Publicado 2022

Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized op...

por Belyavskiy, Evgeny, Ovchinnikov, Artem, Potekhina, Alexandra, Ageev, Fail, Edelmann, Frank
Publicado 2020

Prognostic value of changes in arterial stiffness in men with coronary artery disease

por Orlova, Iana A, Nuraliev, Eradzh Yu, Yarovaya, Elena B, Ageev, Fail T
Publicado 2010

Digital Technology Tools to Examine Patient Adherence to a Prescription-Only Omega-3 Polyunsaturated Fatty Acid Therapy To Mitigate Cardiovascular Risk: Protocol for a Prospective...

por Arutyunov, Gregory P, Arutyunov, Alexander G, Ageev, Fail T, Fofanova, Tatiana V
Publicado 2021

Use of Digital Technology Tools to Characterize Adherence to Prescription-Grade Omega-3 Polyunsaturated Fatty Acid Therapy in Postmyocardial or Hypertriglyceridemic Patients in the...

por Arutyunov, Gregory P, Arutyunov, Alexander G, Ageev, Fail T, Fofanova, Tatiana V
Publicado 2022

Blood Immune Cell Alterations in Patients with Hypertensive Left Ventricular Hypertrophy and Heart Failure with Preserved Ejection Fraction

por Ovchinnikov, Artem, Filatova, Anastasiya, Potekhina, Alexandra, Arefieva, Tatiana, Gvozdeva, Anna, Ageev, Fail, Belyavskiy, Evgeny
Publicado 2023